Radius Health, which is developing treatments to restore bone density in osteoporosis patients, revived its IPO by filing an amended S-1 with the SEC on Wednesday. The company had previously launched a deal to sell 5 million shares at $14 to $16 per share ($411 million cap) but postponed on May 9. Its updated filing removed the original IPO terms. Radius first filed to raise $62 million at a $283 million valuation in November 2012, but withdrew its IPO plans due to poor market conditions.
The Cambridge, MA-based company was founded in 2003 and plans to list on the NASDAQ under the symbol RDUS. Jefferies and Cowen & Company are the joint bookrunners on the deal. Pricing terms were not disclosed.
